Home › Attention Deficit Hyperactivity Disorder › Mississippi
Attention Deficit Hyperactivity Disorder clinical trials in Mississippi
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Mississippi.
Cities in Mississippi
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Precise Research Centers, Flowood
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Jackson
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Jackson
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892A Pilot Study of a Remote ADHD Monitoring Program
- University of Mississippi Medical Center, Jackson
RecruitingHealthy volunteers welcome
Ages 5 to 11 · All sexes · Updated Apr 28, 2026 · NCT06743425From ClinicalTrials.gov, data retrieved Oct 4, 2026. Each study sets its own eligibility; the study team decides who can join.